| Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042) |
|---|
| 08/01/2006 | US7084175 Animal food and method |
| 08/01/2006 | US7083947 Assay techniques using nematode worms |
| 08/01/2006 | US7083940 Polynucleotide encoding a polypeptide which has proteolytic activity for insulin like growth factor binding protein; use in diagnosis of fetal abnormalities |
| 08/01/2006 | CA2375921C Goodpasture's syndrome model mouse |
| 07/27/2006 | WO2006078646A2 A class of supramolecular drug molecules and methods of identification and use thereof |
| 07/27/2006 | WO2006078535A2 Improving embryo development and survival |
| 07/27/2006 | WO2006078072A1 Non-human chimeric animal and use thereof |
| 07/27/2006 | WO2006077989A1 Individually mixed pet feed supply system |
| 07/27/2006 | WO2006077874A1 Polymorphism of gene encoding drug metabolizing enzyme in monkey and the use thereof |
| 07/27/2006 | WO2006014798A3 Methods and compositions for using sax2 |
| 07/27/2006 | WO2005102038A3 Expression of polypeptides in rod outer segment membranes |
| 07/27/2006 | WO2005081904A3 Antimicrobial carbohydrates and methods of using same |
| 07/27/2006 | US20060168674 Mouse cardiac conduction system model |
| 07/27/2006 | US20060168673 Transgenic animals as models for neurodegenerative disease |
| 07/27/2006 | US20060168672 B7-like molecules and uses thereof |
| 07/27/2006 | US20060168671 Injection of caprine sperm factor (cSF), phospholipase C zeta (PLCzeta) and adenophostin A as alternative methods of activation during nuclear transfer in the caprine species |
| 07/27/2006 | US20060168670 identification of new gene families that are differentially expressed in cancerous human tissues compared to normal human tissues; useful as diagnostic agents or markers to detect cancer or to differentiate carcinoma from normal tissue in a sample; nucleotide sequence |
| 07/27/2006 | US20060168669 Gene silencing |
| 07/27/2006 | US20060168668 Phosphodiesterase 2a and methods of use |
| 07/27/2006 | US20060168667 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 07/27/2006 | US20060168666 Autoimmune disease model animal |
| 07/27/2006 | US20060168665 Flourescent proteins as cell type specific reporters |
| 07/27/2006 | US20060167227 Truncated tau proteins |
| 07/27/2006 | US20060167225 Novel fluorescent protein from aequorea coerulscens and methods for using the same |
| 07/27/2006 | US20060166316 Phosphodiesterase 10a7 isoforms and methods of use |
| 07/27/2006 | US20060166260 Visualization of avian eggs |
| 07/27/2006 | US20060166193 Binding protein |
| 07/27/2006 | US20060165689 Compositions and methods for modulation of effects on phagocyte and lymphoid cell populations employing tirc7 |
| 07/27/2006 | US20060165673 proteins having transferase activity comprising amino acid sequences modified to be in detectably labeled form, used for therapy and drug screening |
| 07/27/2006 | US20060162668 Method for cultivating novel species of haliotis discus hannai ino with tangerine color shell |
| 07/27/2006 | CA2595612A1 Methods and compositions related to tr4 |
| 07/27/2006 | CA2594358A1 Improving embryo development and survival |
| 07/26/2006 | EP1683810A1 Method for producing antibodies |
| 07/26/2006 | EP1682890A2 Screening assays and methods of tumor treatment |
| 07/26/2006 | EP1682170A2 Compositions able to prevent neurodegenerative processes and methods of assaying the same |
| 07/26/2006 | EP1681988A2 Method for diagnosis and treatment of pulmonary disorders |
| 07/26/2006 | EP1573314A4 Transgenic mice expressing human cd20 |
| 07/26/2006 | EP1353687B1 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 07/26/2006 | EP1351974B1 Using viruses to detect or purify proteins |
| 07/26/2006 | EP1208216B1 Fatty acid desaturase gene from plants |
| 07/26/2006 | EP1181373B1 Delta6-acetylenase and delta6-desaturase from ceratodon purpureus |
| 07/26/2006 | EP0832222B1 Linc-53 from c. elegans and its uses in listing compounds involved in the control of cell behaviour and pharmaceutical compositions |
| 07/26/2006 | CN1809750A Acetyl-coenzyme A carboxylase 2 as a target in the regulation of fat and insulin action |
| 07/26/2006 | CN1809589A GITR ligand and GITR ligand-related molecules and antibodies and uses thereof |
| 07/26/2006 | CN1806538A Artificial cultivation method of glenea cantor |
| 07/26/2006 | CN1266273C Promoter for regulating and controlling mouse orphan nucleus receptor and its use |
| 07/25/2006 | US7081562 obtained by backcrossing a mouse whose function of immunoglobulin Fc gamma receptor IIB gene is deficient on its chromosome and a wild-type collagen-induced arthritis-susceptible DBA/1J mouse six times or more |
| 07/25/2006 | US7081561 Gene-targeted animal model of apolipoprotein E4 domain interaction and uses thereof |
| 07/20/2006 | WO2006076419A1 Dna markers for cattle growth |
| 07/20/2006 | WO2006076296A2 A non-naturally occurring animal that expresses an untranslated non-coding rna |
| 07/20/2006 | WO2006075187A2 Animals exhibiting an altered preference for an addictive substance |
| 07/20/2006 | WO2006014985A3 Genetic immunization of transgenic animals with non-eukaryotic expression systems |
| 07/20/2006 | US20060162005 Methods for producing transgenic medaka |
| 07/20/2006 | US20060162004 ADAM-like protease disruptions, compositions and methods related thereto |
| 07/20/2006 | US20060162003 protecting a mammalian embryo from embryotoxic effects by administering the prostaglandin F2 alpha receptor antagonist to a recipient female mammal; reduce transplant rejection when transfer embryo in cattle |
| 07/20/2006 | US20060162002 Drug screening; assaying for activators of the heat shock factor 1 (HSF-1) protein, which increases lifespan when overexpressed in an organism; antiaging agents |
| 07/20/2006 | US20060162001 Mammalian grainyhead transcription factors |
| 07/20/2006 | US20060162000 Development and use of a new orthotopic, genetically tractable non-human animal model for liver cancer |
| 07/20/2006 | US20060161999 Reconstituted human breast tumor model |
| 07/20/2006 | US20060161998 Non-traumatic model for neurogenic pain |
| 07/20/2006 | US20060161997 Methods for producing human antibodies in SCID mice |
| 07/20/2006 | US20060161996 Process for producing human-origin immunocompetent cell |
| 07/20/2006 | US20060161995 Chimeric mouse in which at least 85% of the human antibody-producing cells retain the human artificial chromosome Delta HAC or Delta Delta HAC. |
| 07/20/2006 | US20060161994 Functional assays for cholesterol absorption inhibitors |
| 07/20/2006 | US20060159623 Stem cells for use in locating and targeting tumor cells |
| 07/20/2006 | CA2595126A1 Methods and compositions for preventing and treating a disease related to glycan dysregulation |
| 07/20/2006 | CA2594757A1 Dna markers for cattle growth |
| 07/19/2006 | EP1681355A1 Sequence-specific DNA recombination in eukaryotic cells |
| 07/19/2006 | EP1680959A1 Endotoxin-nonresponsive model animal |
| 07/19/2006 | EP1679960A1 Transgenic amphibian models for lymphatic vessel development |
| 07/19/2006 | EP1679959A1 A method for inducing the sexual maturation of lugworms |
| 07/19/2006 | EP1616183A4 Methods of detecting neurological disorders |
| 07/19/2006 | CN2796376Y Check bundle self rotating clamping device for silkworm |
| 07/19/2006 | CN2796375Y Environment controller for silkworm |
| 07/19/2006 | CN1806174A Human G protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders |
| 07/19/2006 | CN1803837A Neurotrophic growth factor |
| 07/19/2006 | CN1802906A Perinereis aibihitensis Grube manual seedling-raising method |
| 07/19/2006 | CN1802905A Big Symphyllia mucilage collection method |
| 07/18/2006 | US7078585 Bacterial cell component-unresponsive model mouse |
| 07/18/2006 | US7078584 Salmonella typhimurium-infected Caenorhabditis elegans for identifying inhibitors of infection |
| 07/18/2006 | US7078515 Sodium-channel alpha1-subunit and their polypeptides and their treatment of generalized epilepsy with febrile seizures plus |
| 07/18/2006 | US7078510 Robust, inducible cardiac preferred expression system for transgenesis |
| 07/18/2006 | US7078196 Genetic engineering ; induction post-transcriptional gene blocking |
| 07/18/2006 | US7078191 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation |
| 07/18/2006 | US7078035 Phytases, nucleic acids encoding them and methods for making and using them |
| 07/13/2006 | WO2006074378A2 Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor |
| 07/13/2006 | WO2006074292A2 Target validation assay |
| 07/13/2006 | WO2006074186A2 Development and use of a new orthotopic genetically tractable non-human animal model for liver cancer |
| 07/13/2006 | WO2006073955A2 Artificial diets for honey bees |
| 07/13/2006 | WO2006073601A2 Methods and compositions for rna interference |
| 07/13/2006 | WO2006073432A2 Mannose-binding lectin knock-out mice and methods of use thereof |
| 07/13/2006 | WO2006072803A2 Antibody |
| 07/13/2006 | WO2006048465A3 Animal models comprising at least one mutation or one conditional ki and one conditional ko |
| 07/13/2006 | WO2005117576A3 Modification of sugar metabolic process in transgenic cells, tissues and animals |
| 07/13/2006 | WO2005112978A3 Methods and compositions related to delivery of chemical compounds to invertebrate embryos |
| 07/13/2006 | WO2005079307A3 Use of il-14 derived tools as therapeutics for malignancies and autoimmune diseases and transgenic animals related to same |
| 07/13/2006 | US20060156426 Transgenic mice containing ABC transporter-like ATPase gene disruptions |
| 07/13/2006 | US20060156425 GNG4 gene disruptions, compositions and methods related thereto |
| 07/13/2006 | US20060156424 Quiescent cell populations for nuclear transfer |
| 07/13/2006 | US20060156423 Method of screening antiobesity agents and animal model of obesity |